The JI
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     
 


This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Wahl, S. M.
Right arrow Articles by Roberts, A. B.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Wahl, S. M.
Right arrow Articles by Roberts, A. B.

The Journal of Immunology, Vol 140, Issue 9 3026-3032, Copyright © 1988 by American Association of Immunologists


ARTICLES

Transforming growth factor-beta is a potent immunosuppressive agent that inhibits IL-1-dependent lymphocyte proliferation

SM Wahl, DA Hunt, HL Wong, S Dougherty, N McCartney-Francis, LM Wahl, L Ellingsworth, JA Schmidt, G Hall and AB Roberts
Cellular Immunology Section, National Institute of Dental Research, Bethesda, MD 20892.

Transforming growth factor-beta (TGF-beta), a product of neoplastic and hemopoietic cells, is a bifunctional regulator of the immune response. At femtomolar concentrations, TGF-beta stimulates monocyte migration, and picomolar quantities induce synthesis of monocyte growth factors, including IL-1, that may promote tissue repair by regulating fibrosis and angiogenesis. Paradoxically, TGF-beta at picomolar concentrations also blocks the ability of IL-1 to stimulate lymphocyte proliferation. At 0.01 to 1.0 ng/ml, TGF-beta 1 and its homologue, TGF-beta 2, suppress the IL-1-dependent murine thymocyte proliferation assay. TGF- beta also inhibits human peripheral blood T lymphocyte mitogenesis. Inhibition of cell division appears to occur after activation of the lymphocytes inasmuch as neither gene expression nor translation of IL- 2R is suppressed. Furthermore, TGF-beta does not block synthesis of IL- 2. Therefore, TGF-beta 1 and TGF-beta 2 likely act at a site distal to IL-1 to block lymphocyte DNA synthesis. These findings suggest that TGF- beta secreted in an inflammatory site may be beneficial in diminishing lymphocyte function while promoting fibrosis and tissue repair. However, TGF-beta generated by neoplastic tissues may provide a mechanism for unrestricted tumor cell growth through its selective immunosuppressive effects.


This article has been cited by other articles:


Home page
J ANIM SCIHome page
D. D. Bannerman
Pathogen-dependent induction of cytokines and other soluble inflammatory mediators during intramammary infection of dairy cows
J Anim Sci, April 1, 2009; 87(13_suppl): 10 - 25.
[Abstract] [Full Text] [PDF]


Home page
J. Leukoc. Biol.Home page
A. W. Taylor
Review of the activation of TGF-{beta} in immunity
J. Leukoc. Biol., January 1, 2009; 85(1): 29 - 33.
[Abstract] [Full Text] [PDF]


Home page
J. Cell Sci.Home page
P. S. Acharya, S. Majumdar, M. Jacob, J. Hayden, P. Mrass, W. Weninger, R. K. Assoian, and E. Pure
Fibroblast migration is mediated by CD44-dependent TGF{beta} activation
J. Cell Sci., May 1, 2008; 121(9): 1393 - 1402.
[Abstract] [Full Text] [PDF]


Home page
ReproductionHome page
S. C. Das, N. Isobe, M. Nishibori, and Y. Yoshimura
Expression of transforming growth factor-{beta} isoforms and their receptors in utero-vaginal junction of hen oviduct in presence or absence of resident sperm with reference to sperm storage.
Reproduction, November 1, 2006; 132(5): 781 - 790.
[Abstract] [Full Text] [PDF]


Home page
Rheumatology (Oxford)Home page
M. Dziadzio, R. E. Smith, D. J. Abraham, C. M. Black, and C. P. Denton
Circulating levels of active transforming growth factor {beta}1 are reduced in diffuse cutaneous systemic sclerosis and correlate inversely with the modified Rodnan skin score
Rheumatology, December 1, 2005; 44(12): 1518 - 1524.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Gastrointest. Liver Physiol.Home page
Y. Motomura, H. Kanbayashi, W. I. Khan, Y. Deng, P. A. Blennerhassett, P. J. Margetts, J. Gauldie, K. Egashira, and S. M. Collins
The gene transfer of soluble VEGF type I receptor (Flt-1) attenuates peritoneal fibrosis formation in mice but not soluble TGF-{beta} type II receptor gene transfer
Am J Physiol Gastrointest Liver Physiol, January 1, 2005; 288(1): G143 - G150.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
C. Jackaman, C. S. Bundell, B. F. Kinnear, A. M. Smith, P. Filion, D. van Hagen, B. W. S. Robinson, and D. J. Nelson
IL-2 Intratumoral Immunotherapy Enhances CD8+ T Cells That Mediate Destruction of Tumor Cells and Tumor-Associated Vasculature: A Novel Mechanism for IL-2
J. Immunol., November 15, 2003; 171(10): 5051 - 5063.
[Abstract] [Full Text] [PDF]


Home page
Rheumatology (Oxford)Home page
J. Vencovsky, E. Zd'arsky, S. P. Moyes, A. Hajeer, S. Ruzickova, Z. Cimburek, W. E. Ollier, R. N. Maini, and R. A. Mageed
Polymorphism in the immunoglobulin VH gene V1-69 affects susceptibility to rheumatoid arthritis in subjects lacking the HLA-DRB1 shared epitope
Rheumatology, April 1, 2002; 41(4): 401 - 410.
[Abstract] [Full Text] [PDF]


Home page
Eur Heart J SupplHome page
G.K. Hansson
The stabilized plaque: will the dream come true?
Eur. Heart J. Suppl., June 1, 2001; 3(suppl_C): C69 - C75.
[PDF]


Home page
J. Immunol.Home page
A. Schwarz, S. Beissert, K. Grosse-Heitmeyer, M. Gunzer, J. A. Bluestone, S. Grabbe, and T. Schwarz
Evidence for Functional Relevance of CTLA-4 in Ultraviolet-Radiation-Induced Tolerance
J. Immunol., August 15, 2000; 165(4): 1824 - 1831.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
F. W. v. Ginkel, S. M. Wahl, J. F. Kearney, M.-N. Kweon, K. Fujihashi, P. D. Burrows, H. Kiyono, and J. R. McGhee
Partial IgA-Deficiency with Increased Th2-Type Cytokines in TGF-{beta}1 Knockout Mice
J. Immunol., August 15, 1999; 163(4): 1951 - 1957.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
S. W. Kauma, T. F. Huff, N. Hayes, and A. Nilkaeo
Placental Fas Ligand Expression Is a Mechanism for Maternal Immune Tolerance to the Fetus
J. Clin. Endocrinol. Metab., June 1, 1999; 84(6): 2188 - 2194.
[Abstract] [Full Text]


Home page
Infect. Immun.Home page
M. Galdiero, A. Marcatili, G. Cipollaro de l'ero, I. Nuzzo, C. Bentivoglio, M. Galdiero, and C. R. Carratelli
Effect of Transforming Growth Factor beta  on Experimental Salmonella typhimurium Infection in Mice
Infect. Immun., March 1, 1999; 67(3): 1432 - 1438.
[Abstract] [Full Text] [PDF]


Home page
LupusHome page
M L Huggins, F-P Huang, D Xu, G Lindop, and D I Stott
Modulation of autoimmune disease in the MRL-lpr/lpr mouse by IL-2 and TGF-{beta}1 gene therapy using attenuated Salmonella typhimurium as gene carrier
Lupus, January 1, 1999; 8(1): 29 - 38.
[Abstract] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
S. H. Han, S. S. Yea, Y. J. Jeon, K.-H. Yang, and N. E. Kaminski
Transforming Growth Factor-Beta 1 (TGF-beta 1) Promotes IL-2 mRNA Expression Through the Up-regulation of NF-kappa B, AP-1 and NF-AT in EL4 Cells
J. Pharmacol. Exp. Ther., December 1, 1998; 287(3): 1105 - 1112.
[Abstract] [Full Text]


Home page
J. Immunol.Home page
W. Chen, W. Jin, M. Cook, H. L. Weiner, and S. M. Wahl
Oral Delivery of Group A Streptococcal Cell Walls Augments Circulating TGF-{beta} and Suppresses Streptococcal Cell Wall Arthritis
J. Immunol., December 1, 1998; 161(11): 6297 - 6304.
[Abstract] [Full Text] [PDF]


Home page
JEMHome page
W. Chen, W. Jin, and S. M. Wahl
Engagement of Cytotoxic T Lymphocyte-associated Antigen 4 (CTLA-4) Induces Transforming Growth Factor {beta} (TGF-{beta}) Production by Murine CD4+ T Cells
J. Exp. Med., November 16, 1998; 188(10): 1849 - 1857.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
M. Brunetti, A. Colasante, N. Mascetra, M. Piantelli, P. Musiani, and F. B. Aiello
IL-10 Synergizes with Dexamethasone in Inhibiting Human T Cell Proliferation
J. Pharmacol. Exp. Ther., May 1, 1998; 285(2): 915 - 919.
[Abstract] [Full Text]


Home page
Proc. Natl. Acad. Sci. USAHome page
C. S. Hirsch, J. J. Ellner, R. Blinkhorn, and Z. Toossi
In vitro restoration of T cell responses in tuberculosis and augmentation of monocyte effector function against Mycobacterium tuberculosis by natural inhibitors of transforming growth factor beta
PNAS, April 15, 1997; 94(8): 3926 - 3931.
[Abstract] [Full Text] [PDF]


Home page
Arch SurgHome page
I. Karres, J.-P. Kremer, U. Steckholzer, J. S. Kenney, and W. Ertel
Transforming Growth Factor-{beta}1 Inhibits Synthesis of Cytokines in Endotoxin-Stimulated Human Whole Blood
Arch Surg, December 1, 1996; 131(12): 1310 - 1317.
[Abstract] [PDF]


Home page
CROBMHome page
C. Feliciani, A.K. Gupta, and D.N. Saucier
Keratinocytes and Cytokine/Growth Factors
Critical Reviews in Oral Biology & Medicine, January 1, 1996; 7(4): 300 - 318.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
C. M. Dubois, M.-Hélèn. Laprise, F. Blanchette, L. E. Gentry, and R. Leduc
Processing of Transforming Growth Factor [IMAGE]1 Precursor by Human Furin Convertase
J. Biol. Chem., May 5, 1995; 270(18): 10618 - 10624.
[Abstract] [Full Text] [PDF]


Home page
LupusHome page
G. Del Giudice and M. K. Crow
Review: Role of Transforming Growth Factor Beta (TGF{beta}) in Systemic Autoimmunity
Lupus, August 1, 1993; 2(4): 213 - 220.
[Abstract] [PDF]


Home page
ScienceHome page
M Barral-Netto, A Barral, C. Brownell, Y. Skeiky, L. Ellingsworth, D. Twardzik, and S. Reed
Transforming growth factor-beta in leishmanial infection: a parasite escape mechanism
Science, July 24, 1992; 257(5069): 545 - 548.
[Abstract] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Website Copyright © 1988 by The American Association of Immunologists, Inc. All rights reserved.
All Contents Copyright © 1988 by The American Association of Immunologists, Inc. All rights reserved.